We aim to explore the role of semaphorin 7A (SEMA7A) and its receptor plexin C1 in the migration of NSCLC cells. In the present study, expression of SEMA7A and plexin C1 in A549 cells and H1299 cells were detected by western blot. The effect of interaction between SEMA7A and plexin C1 in cell migration and migration related signaling pathway was detected using recombinant SEMA7A and plexin C1 small interfering RNA (siRNA). Both cells showed an increase in SEMA7A and plexin C1 expression compared with normal alveolar epithelial cells. In addition, SEMA7A activated tumor migration by increasing phosphorylation of its related protein FAK, LIMKII and actin-binding protein cofilin, which are also downstream targets of plexin C1. However, SEMA7A failed to activate cell migration and its related protein FAK, LIMKII and cofilin when plexin C1 was silenced. These results suggest that the interaction between SEMA7A and plexin C1 promoted migration of A549 cells and H1299 cells and this effect worked through actin-binding protein cofilin signaling activation.
Introduction
Semaphorins comprise a large class of transmembrane and secreted proteins and they have been divided into eight subfamilies based on sequence similarities and distinct structural features. [1] [2] [3] Semaphorins were originally identied as axon guidance molecules in developing nervous system.
2 All semaphorins are characterized by a conserved Sema domain ($500 amino acids) in the N-amino terminus. Besides the function of neuronal guidance, semaphorins were found to be present in a variety of cells and they also have some other effects including modulation of vessel development, regulating immune responses. Several studies demonstrated that some semaphorins participated in tumor growth. They have been identied to affect cancer progression through modulating cancer angiogenesis and changing the behavior of cancer cells.
Semaphorin 7A (SEMA7A) is a membrane-associated GPI (glycosyl phosphatidylinositol)-linked semaphorin and it was also initially identied as a neuronal guidance protein. SEMA7A has been showed to function through interaction with receptor plexin C1 and b1-integrin. As regards to the SEMA7A receptors involved in the cell migration process, several works associate b1-integrin with immunomodulatory function. [4] [5] [6] [7] However, plexin C1 have been associated with cell adhesion, dendricity and cytoskeletal reorganization. [8] [9] [10] Recent studies showed that SEMA7A also has effect in cancer progression. In glioblastoma, SEMA7A expressed by cancer cells contributed to the highly invasive phenotype.
11
SEMA7A can also skew macrophages into a pro-tumorigenic state to promote tumor progression in mammary carcinoma.
12
However, interaction between SEMA7A and plexin C1 plays a different role in melanoma. 13 Plexin C1 is absent in human melanoma cell lines and the loss of plexin C1 has been regarded as a critical factor of melanoma invasion and metastasis.
Focal adhesion kinase (FAK) and colin pathway are strongly linked to the tumor adhesion, migration and progression.
14-19
Colin is an actin binding protein involved in actin disassembly and is downstream target of LIM kinases (LIMK), which can phosphorylate colin on Ser-33. LIMK include two isoforms, LIMKI and LIMKII. 20 LIMKI is only expressed in neural cells and LIMKII is widely expressed. Previous study has showed that colin is also a downstream target of plexin C1. 13 Recently, we found that SEMA7A and plexin C1 were highly expressed in lung cancer cells. However, the role of SEMA7A-plexin C1 in NSCLC (non-small cell lung cancer) cell migration and its specic mechanism are not clear.
In this study, we explored the interaction between SEMA7A and its receptor plexin C1 in lung cancer A549 cell and H1299 cell migration. In addition, we also investigated the changes of tumor migration related signaling pathway. The results of our study suggested that SEMA7A and plexin C1 highly expressed in both cells. The interaction between SEMA7A and its receptor plexin C1 promoted the migration of both cells and activated tumor migration related proteins FAK, LIMKII and colin.
cancer (NSCLC) cell line A549 and H1299 (obtained from ATCC, Rockville, MD, USA), were maintained in RPMI 1640 medium supplemented with 100 U ml À1 of penicillin-streptomycin and 10% fetal bovine serum (FBS) at 37 C in a humidied atmosphere containing 5% CO 2 and 95% air. Specic siRNA for plexin C1 and the scramble control siRNA were purchased from Genechem (Shanghai, China of target cDNA was determined by arbitrarily setting the control value to 1 and changes in cDNA content of a sample were expressed as a multiple thereof. Genes and primers are listed as follows: the sequences of the human SEMA7A primers were 5 
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The sequences of the human b-actin primers were 5 0 -TGGCACCCAGCACAATGAA-3 0 (forward) and 5 0 -CTAAGTCATA GTCCGCCTAGAAGCA-3 0 (reverse). All data were obtained with 0 ng ml À1 rSEMA7A stimulation. n ¼ 8, *P < 0.05, **P < 0.01 and ***P < 0.001 versus group Scr siRNA. (B) All data were obtained with 100 ng ml À1 rSEMA7A stimulation for 5 or 15 min. n ¼ 8, ***P < 0.001 versus rSEMA7A for 5 min + scramble siRNA group, ###P < 0.001 versus rSEMA7A for 15 min + scramble siRNA group.
Western blot analysis
Image lab soware (Bio-Rad, Hercules, CA, USA), and the relative expressions of the target proteins were calculated by the ratio of the IOD value of the target band and the IOD value of the corresponding internal reference (b-actin).
Wound scratch assay
A549 cells or H1299 cells (2 Â 10 5 cells per hole in 6 wells plates)
were seeded in growth medium and the siRNA was transiently transfected into cells. 48 h aer transfection, cells were treated with or without rSEMA7A. A straight line scratch was made on cell layers using a sterile 1 ml disposable serological pipette. Images of cell migration were taken using microscope at 0 h and 24 h aer the scratch. The cells were counted manually at 24 h post scratch from 6 images and the data are presented with standard deviations.
Transwell assay
48 h aer transfection, cells were cultured in serum free medium treated with or without rSEMA7A for 12 h. The cells then digested and suspended in serum free medium. The transwell experiments were performed in 24 well transwell plates. 200 ml cell suspension was added in the upper chamber and the lower chamber was added with 800 ml RPMI 1640 medium containing 10% FBS. Then the plates were incubated in 5% CO 2 under 37 C. 24 h later, cells were xed with 4%
paraformaldehyde for 30 min and the chambers were subjected to 0.2% Triton X-100 for 15 min and 0.05% gentian violet dye for 5 min. The number of stained cells were counted under inverted microscope.
Statistical analysis
All data are expressed as mean AE SD and statistical analysis were performed with one-way ANOVA followed by Dunnett's test. Statistical difference was accepted if P < 0.05.
Results

SEMA7A and its receptor plexin C1 upregulated in NSCLC A549 cells
As shown in Fig. 1 , expression of SEMA7A and its receptor plexin C1 were signicantly higher in NSCLC A549 cells compared with normal human pulmonary alveolar epithelial cells both in mRNA and protein level (P < 0.001). However, expression of b1-integrin in A549 cells was on levels of normal cells.
SEMA7A and its receptor plexin C1 upregulated in NSCLC H1299 cells
As shown in Fig. 2 , expression of SEMA7A and its receptor plexin C1 were signicantly higher in NSCLC H1299 cells compared with normal human pulmonary alveolar epithelial cells both in mRNA and protein level (P < 0.01). However, expression of b1-integrin in H1299 cells was on levels of normal cells. Fig. 6 Knockdown of plexin C1 decreases the expression of LIMKII, inhibits phosphorylation of FAK and cofilin in NSCLC H1299 cells. All data were obtained with 100 ng ml À1 rSEMA7A stimulation for 5 or 15 min. n ¼ 8, ***P < 0.001 versus rSEMA7A for 5 min + scramble siRNA group, ###P < 0.001 versus rSEMA7A for 15 min + scramble siRNA group.
SEMA7A activates the expression of LIMKII, stimulates phosphorylation of FAK and colin in NSCLC A549 cells
To assess the role of SEMA7A on tumor migration related signaling pathways, we explored the effect of SEMA7A on activation of FAK and colin pathways in A549 cells using rSEMA7A. A549 cells were treated with rSEMA7A at doses ranging from 1 to 100 ng ml À1 for 15 min. Control group was treated with vehicle.
As shown in Fig. 3 , the expression of LIMKII, phosphorylated FAK and colin were signicantly promoted as the increase of rSEMA7A doses. Maximal FAK and colin phosphorylation were observed at 100 ng ml À1 and maximal LIMKII were observed at 50 ng ml À1 .
SEMA7A activates the expression of LIMKII, stimulates phosphorylation of FAK and colin in NSCLC H1299 cells
We also explored the role of SEMA7A on tumor migration related signaling pathways in H1299 cells. H1299 cells were treated with rSEMA7A at doses ranging from 1 to 100 ng ml À1 for 15 min. Control group was treated with vehicle. As shown in Fig. 4 , the expression of LIMKII, phosphorylated FAK and colin were signicantly promoted as the increase of rSEMA7A doses.
Knockdown of plexin C1 decreases the expression of LIMKII, inhibits phosphorylation of FAK and colin in NSCLC A549 cells
To assess the role of plexin C1 on tumor migration related signaling pathways, we explored the effect of interaction between SEMA7A and plexin C1 on activation of FAK and colin pathways in A549 cells using rSEMA7A. 48 h aer siRNA transfection, A549 cells were treated with rSEMA7A (0 ng ml À1 or 100 ng ml À1 ) for 5 or 15 min. As shown in Fig. 5A and B, knockdown of plexin C1 decreased the expression of LIMKII, inhibited phosphorylation of FAK and colin in A549 cells compared with scramble siRNA group. In addition, the effect of inhibition in 15 min group was signicant compared with 5 min group.
Knockdown of plexin C1 decreases the expression of LIMKII, inhibits phosphorylation of FAK and colin in NSCLC H1299 cells
We also explored the role of plexin C1 on tumor migration related signaling pathways in H1299 cells. 48 h aer siRNA transfection, cells were treated with rSEMA7A (100 ng ml À1 ) for 5 or 15 min. As shown in Fig. 6 , knockdown of plexin C1 decreased the expression of LIMKII, inhibited phosphorylation of FAK and colin in H1299 cells compared with scramble siRNA group.
Knockdown of plexin C1 inhibits the cell migration in NSCLC A549 cells stimulated by rSEMA7A
To investigate the role of plexin C1 on cell migration, we explored the effect of interaction between SEMA7A and plexin C1 on A549 cells using wound scratch assay and transwell assay. 48 h aer siRNA transfection, A549 cells were treated with rSEMA7A (100 ng ml À1 ). As shown in Fig. 7A, rSEMA7A treatment promoted cell migration aer 24 h. However, treatment with plexin C1 siRNA decreased the cell migration aer 24 h. The same result is also shown in transwell assay (Fig. 7B ).
Knockdown of plexin C1 inhibits the cell migration in NSCLC H1299 cells stimulated by rSEMA7A
We also investigated the role of plexin C1 on H1299 cell migration. 48 h aer siRNA transfection, H1299 cells were treated with rSEMA7A (100 ng ml À1 ). As shown in Fig. 8A , rSE-MA7A treatment promoted cell migration aer 24 h. However, treatment with plexin C1 siRNA decreased the cell migration aer 24 h. The same result is also shown in transwell assay (Fig. 8B ).
Discussion
In this study, we explored the role of SEMA7A and its receptor plexin C1 in the migration of NSCLC cells. The results showed that SEMA7A and its receptor plexin C1 were highly expressed in NSCLC A549 cells and H1299 cells. In addition, treatment with rSEMA7A activated the tumor migration related pathway FAK and colin in both cells. However, knockdown of plexin C1 reduced the actin-dependent cell migration, decreased the expression of LIMKII and inhibited phosphorylation of FAK and colin in A549 cells and H1299 cells. SEMA7A was initially found to regulate neurite growth and axon track formation during embryonic development.
21
SEMA7A is also involved in immune responses such as modulation of T cell function, stimulation of macrophage recruitment and pro-inammatory cytokine production, regulation of chemokine expression and dendritic cell migration. [4] [5] [6] [7] [8] 22, 23 During the recent past years, several studies have shown that SEMA7A has effect in cancer progression.
10-12 SEMA7A worked through interaction with its receptor plexin C1 and b1-integrin. Previous studies have shown that b1-integrin is associated with immunomodulatory function and plexin C1 was associated with cell adhesion, dendricity and cytoskeletal reorganization. [4] [5] [6] [7] In our present study, we found that SEMA7A and its receptor plexin C1 were highly expressed in NSCLC A549 cells and H1299 cells. Therefore, we explored the effect of interaction between SEMA7A and plexin C1 on NSCLC A549 cell and H1299 cell migration and its related signaling pathways. FAK and colin pathway are strongly linked to the tumor adhesion, migration and progression. FAK is the key component of the focal adhesion complex, which links focal adhesions to the cytosolic signaling pathway. 24 Phosphorylation of FAK can regulate the cell cytoskeleton. Colin is an actin binding protein involved in actin disassembly and is downstream target of LIMK. 17 Previous studies showed that activation of integrin induced phosphorylation of FAK.
14 However, expression of b1-integrin in A549 cells and H1299 cells remained very low. In our study, SEMA7A activates the expression of LIMKII, stimulates phosphorylation of FAK and colin in A549 cells and H1299 cells. Activation of these signaling pathways ultimately induced increase of stress bers, lopodia and membrane ruffles, promoted cell motility. Moreover, knockdown of plexin C1 inhibited FAK and colin phosphorylation aer rSEMA7A stimulation. Most interestingly, our ndings in NSCLC cell line are different with melanoma cell line in some aspects. Plexin C1 is absent in melanoma cell line. However, colin and its related signaling pathway are also activated in melanoma. This phenomenon is different from our ndings. Unlike melanoma, plexin C1 is highly expressed in NSCLC cells and activation of colin is depended on interaction between SEMA7A and plexin C1. Some studies 25 about melanoma indicated that plexin C1 contains an intrinsic Ras-GTPase activating domain which resulting in exchange of GTP for GDP on R-Ras. Therefore, the expression of lexin C1 inactivated the R-Ras. But, R-Ras is a key factor in regulation of melanoma migration. For this reason, loss of plexin C1 in melanoma cell line increased cell adhesion and migration via activation of R-Ras. From these difference we can see that the mechanisms of plexin C1 function in cell migration are multifactorial. In future studies, we will exam some other aspects between plexin C1 and NSCLC cell migration to make this mechanism more explicit. In addition, the mechanism of LIMKII upregulation (gene expression or post translation) is not clear in this study. We will explore the way of LIMKII upregulation in the future studies.
In summary, our experiments demonstrated the roles of SEMA7A and its receptor plexin C1 in NSCLC cell migration. These ndings showed that SEMA7A and plexin C1 triggered cell migration via activating FAK and colin signaling pathways. It may be considered as a potential therapeutic target for the treatment of NSCLC.
